Literature DB >> 24373285

A paired RNAi and RabGAP overexpression screen identifies Rab11 as a regulator of β-amyloid production.

Vinod Udayar1, Virginie Buggia-Prévot2, Rita L Guerreiro3, Gabriele Siegel4, Naresh Rambabu5, Amanda L Soohoo6, Moorthi Ponnusamy5, Barbara Siegenthaler4, Jitin Bali7, Mikael Simons8, Jonas Ries9, Manojkumar A Puthenveedu6, John Hardy3, Gopal Thinakaran2, Lawrence Rajendran10.   

Abstract

Alzheimer's disease (AD) is characterized by cerebral deposition of β-amyloid (Aβ) peptides, which are generated from amyloid precursor protein (APP) by β- and γ-secretases. APP and the secretases are membrane associated, but whether membrane trafficking controls Aβ levels is unclear. Here, we performed an RNAi screen of all human Rab-GTPases, which regulate membrane trafficking, complemented with a Rab-GTPase-activating protein screen, and present a road map of the membrane-trafficking events regulating Aβ production. We identify Rab11 and Rab3 as key players. Although retromers and retromer-associated proteins control APP recycling, we show that Rab11 controlled β-secretase endosomal recycling to the plasma membrane and thus affected Aβ production. Exome sequencing revealed a significant genetic association of Rab11A with late-onset AD, and network analysis identified Rab11A and Rab11B as components of the late-onset AD risk network, suggesting a causal link between Rab11 and AD. Our results reveal trafficking pathways that regulate Aβ levels and show how systems biology approaches can unravel the molecular complexity underlying AD.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24373285      PMCID: PMC4004174          DOI: 10.1016/j.celrep.2013.12.005

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  74 in total

Review 1.  Rab proteins as membrane organizers.

Authors:  M Zerial; H McBride
Journal:  Nat Rev Mol Cell Biol       Date:  2001-02       Impact factor: 94.444

2.  Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease.

Authors:  Li-Bang Yang; Kristina Lindholm; Riqiang Yan; Martin Citron; Weiming Xia; Xiao-Li Yang; Thomas Beach; Lucia Sue; Philip Wong; Donald Price; Rena Li; Yong Shen
Journal:  Nat Med       Date:  2003-01       Impact factor: 53.440

3.  A complete genetic analysis of neuronal Rab3 function.

Authors:  Oliver M Schlüter; Frank Schmitz; Reinhard Jahn; Christian Rosenmund; Thomas C Südhof
Journal:  J Neurosci       Date:  2004-07-21       Impact factor: 6.167

4.  The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease.

Authors:  Ekaterina Rogaeva; Yan Meng; Joseph H Lee; Yongjun Gu; Toshitaka Kawarai; Fanggeng Zou; Taiichi Katayama; Clinton T Baldwin; Rong Cheng; Hiroshi Hasegawa; Fusheng Chen; Nobuto Shibata; Kathryn L Lunetta; Raphaelle Pardossi-Piquard; Christopher Bohm; Yosuke Wakutani; L Adrienne Cupples; Karen T Cuenco; Robert C Green; Lorenzo Pinessi; Innocenzo Rainero; Sandro Sorbi; Amalia Bruni; Ranjan Duara; Robert P Friedland; Rivka Inzelberg; Wolfgang Hampe; Hideaki Bujo; You-Qiang Song; Olav M Andersen; Thomas E Willnow; Neill Graff-Radford; Ronald C Petersen; Dennis Dickson; Sandy D Der; Paul E Fraser; Gerold Schmitt-Ulms; Steven Younkin; Richard Mayeux; Lindsay A Farrer; Peter St George-Hyslop
Journal:  Nat Genet       Date:  2007-01-14       Impact factor: 38.330

Review 5.  Presenilin: running with scissors in the membrane.

Authors:  Dennis J Selkoe; Michael S Wolfe
Journal:  Cell       Date:  2007-10-19       Impact factor: 41.582

Review 6.  Building gamma-secretase: the bits and pieces.

Authors:  Dragana Spasic; Wim Annaert
Journal:  J Cell Sci       Date:  2008-02-15       Impact factor: 5.285

7.  A mutation in APP protects against Alzheimer's disease and age-related cognitive decline.

Authors:  Thorlakur Jonsson; Jasvinder K Atwal; Stacy Steinberg; Jon Snaedal; Palmi V Jonsson; Sigurbjorn Bjornsson; Hreinn Stefansson; Patrick Sulem; Daniel Gudbjartsson; Janice Maloney; Kwame Hoyte; Amy Gustafson; Yichin Liu; Yanmei Lu; Tushar Bhangale; Robert R Graham; Johanna Huttenlocher; Gyda Bjornsdottir; Ole A Andreassen; Erik G Jönsson; Aarno Palotie; Timothy W Behrens; Olafur T Magnusson; Augustine Kong; Unnur Thorsteinsdottir; Ryan J Watts; Kari Stefansson
Journal:  Nature       Date:  2012-08-02       Impact factor: 49.962

8.  Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.

Authors:  A M Cataldo; C M Peterhoff; J C Troncoso; T Gomez-Isla; B T Hyman; R A Nixon
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

9.  Analysis of the gamma-secretase interactome and validation of its association with tetraspanin-enriched microdomains.

Authors:  Tomoko Wakabayashi; Katleen Craessaerts; Leen Bammens; Mostafa Bentahir; Filip Borgions; Piet Herdewijn; An Staes; Evy Timmerman; Joël Vandekerckhove; Eric Rubinstein; Claude Boucheix; Kris Gevaert; Bart De Strooper
Journal:  Nat Cell Biol       Date:  2009-10-18       Impact factor: 28.824

10.  Rab5c promotes AMAP1-PRKD2 complex formation to enhance β1 integrin recycling in EGF-induced cancer invasion.

Authors:  Yasuhito Onodera; Jin-Min Nam; Ari Hashimoto; Jim C Norman; Hiroki Shirato; Shigeru Hashimoto; Hisataka Sabe
Journal:  J Cell Biol       Date:  2012-06-25       Impact factor: 10.539

View more
  54 in total

1.  A comprehensive proteomics analysis of JC virus Agnoprotein-interacting proteins: Agnoprotein primarily targets the host proteins with coiled-coil motifs.

Authors:  A Sami Saribas; Prasun K Datta; Mahmut Safak
Journal:  Virology       Date:  2019-10-20       Impact factor: 3.616

2.  Expression profiling of precuneus layer III cathepsin D-immunopositive pyramidal neurons in mild cognitive impairment and Alzheimer's disease: Evidence for neuronal signaling vulnerability.

Authors:  Bin He; Sylvia E Perez; Sang H Lee; Stephen D Ginsberg; Michael Malek-Ahmadi; Elliott J Mufson
Journal:  J Comp Neurol       Date:  2020-05-05       Impact factor: 3.215

Review 3.  Impact of late-onset Alzheimer's genetic risk factors on beta-amyloid endocytic production.

Authors:  Cláudia Guimas Almeida; Farzaneh Sadat Mirfakhar; Catarina Perdigão; Tatiana Burrinha
Journal:  Cell Mol Life Sci       Date:  2018-04-27       Impact factor: 9.261

4.  Defective Transcytosis of APP and Lipoproteins in Human iPSC-Derived Neurons with Familial Alzheimer's Disease Mutations.

Authors:  Grace Woodruff; Sol M Reyna; Mariah Dunlap; Rik Van Der Kant; Julia A Callender; Jessica E Young; Elizabeth A Roberts; Lawrence S B Goldstein
Journal:  Cell Rep       Date:  2016-10-11       Impact factor: 9.423

Review 5.  Insulin resistance in Alzheimer's disease.

Authors:  Kelly T Dineley; Jordan B Jahrling; Larry Denner
Journal:  Neurobiol Dis       Date:  2014-09-16       Impact factor: 5.996

Review 6.  Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease.

Authors:  Riqiang Yan; Qingyuan Fan; John Zhou; Robert Vassar
Journal:  Neurosci Biobehav Rev       Date:  2016-04-01       Impact factor: 8.989

7.  Bin1 and CD2AP polarise the endocytic generation of beta-amyloid.

Authors:  Florent Ubelmann; Tatiana Burrinha; Laura Salavessa; Ricardo Gomes; Cláudio Ferreira; Nuno Moreno; Cláudia Guimas Almeida
Journal:  EMBO Rep       Date:  2016-11-28       Impact factor: 8.807

8.  Par3 and aPKC regulate BACE1 endosome-to-TGN trafficking through PACS1.

Authors:  Miao Sun; Huaye Zhang
Journal:  Neurobiol Aging       Date:  2017-09-21       Impact factor: 4.673

9.  Significance of transcytosis in Alzheimer's disease: BACE1 takes the scenic route to axons.

Authors:  Virginie Buggia-Prévot; Gopal Thinakaran
Journal:  Bioessays       Date:  2015-06-30       Impact factor: 4.345

10.  Alzheimer disease: modeling an Aβ-centered biological network.

Authors:  D Campion; C Pottier; G Nicolas; K Le Guennec; A Rovelet-Lecrux
Journal:  Mol Psychiatry       Date:  2016-03-29       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.